Chemomab Therapeutics Ltd Sustainability Reports
Chemomab Therapeutics Ltd. is a clinical-stage biotechnology company focused on discovering and developing therapeutics for fibrotic and inflammatory diseases. Its lead product candidate is nebokitug, a humanized monoclonal antibody designed to treat primary sclerosing cholangitis and systemic sclerosis.
Sector: Manufacturing
Country: Israel
Exchange: Nasdaq
ISIN: US16385C1045
5 reports from 2019 to 2025